Evolent Health (EVH) and Its Peers Head to Head Comparison

Evolent Health (NYSE: EVH) is one of 18 public companies in the “Medical Software & Technology Services” industry, but how does it contrast to its rivals? We will compare Evolent Health to similar companies based on the strength of its profitability, dividends, valuation, analyst recommendations, institutional ownership, earnings and risk.

Valuation and Earnings

This table compares Evolent Health and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Evolent Health $361.53 million -$51.15 million -13.72
Evolent Health Competitors $376.98 million $34.79 million 8.34

Evolent Health’s rivals have higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Evolent Health and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Evolent Health -17.57% -6.44% -5.13%
Evolent Health Competitors -18.12% -11.70% -2.05%

Analyst Ratings

This is a breakdown of current recommendations for Evolent Health and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evolent Health 0 0 12 1 3.08
Evolent Health Competitors 72 392 764 10 2.58

Evolent Health presently has a consensus price target of $28.45, indicating a potential upside of 71.41%. As a group, “Medical Software & Technology Services” companies have a potential upside of 19.24%. Given Evolent Health’s stronger consensus rating and higher probable upside, equities analysts clearly believe Evolent Health is more favorable than its rivals.

Insider & Institutional Ownership

82.5% of Evolent Health shares are held by institutional investors. Comparatively, 59.5% of shares of all “Medical Software & Technology Services” companies are held by institutional investors. 8.8% of Evolent Health shares are held by company insiders. Comparatively, 24.0% of shares of all “Medical Software & Technology Services” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Risk & Volatility

Evolent Health has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Comparatively, Evolent Health’s rivals have a beta of 1.33, indicating that their average share price is 33% more volatile than the S&P 500.

Summary

Evolent Health beats its rivals on 8 of the 12 factors compared.

Evolent Health Company Profile

Evolent Health, Inc. is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models. The Company’s services include providing its customers, with a population management platform, integrated data and analytics capabilities, pharmacy benefit management (PBM) services and comprehensive health plan administration services. Its value-based operations are empowered and supported by Identifi. Identifi is the Company’s technology platform that aggregates and analyzes data, manages care workflows and engages patients.

Receive News & Ratings for Evolent Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply